Trial Profile
A Multi-Center, Open Label, Two Part, Dose Escalation Study To Determine The Tolerability Of Interferon-Beta Gene Transfer (BG00001) [interferon-beta gene therapy] In The Treatment Of Recurrent Or Progressive Glioblastoma Multiforme
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 Jun 2009
Price :
$35
*
At a glance
- Drugs Interferon-beta gene therapy (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 10 Oct 2005 New trial record.